569 related articles for article (PubMed ID: 34882034)
1. Assessing Determinants of COVID-19 Vaccine Hesitancy in Nevada.
Coughenour C; Gakh M; Sharma M; Labus B; Chien LC
Health Secur; 2021 Nov; 19(6):592-604. PubMed ID: 34882034
[TBL] [Abstract][Full Text] [Related]
2. Factors Associated With the Intention to Receive the COVID-19 Vaccine: Cross-sectional National Study.
Kasting ML; Macy JT; Grannis SJ; Wiensch AJ; Lavista Ferres JM; Dixon BE
JMIR Public Health Surveill; 2022 Nov; 8(11):e37203. PubMed ID: 36219842
[TBL] [Abstract][Full Text] [Related]
3. Determinants of COVID-19 skepticism and SARS-CoV-2 vaccine hesitancy: findings from a national population survey of U.S. adults.
Levin J; Bradshaw M
BMC Public Health; 2022 May; 22(1):1047. PubMed ID: 35614396
[TBL] [Abstract][Full Text] [Related]
4. Time trends, factors associated with, and reasons for COVID-19 vaccine hesitancy: A massive online survey of US adults from January-May 2021.
King WC; Rubinstein M; Reinhart A; Mejia R
PLoS One; 2021; 16(12):e0260731. PubMed ID: 34932583
[TBL] [Abstract][Full Text] [Related]
5. The Association of Social Factors and Health Insurance Coverage with COVID-19 Vaccinations and Hesitancy, July 2021.
Ku L
J Gen Intern Med; 2022 Feb; 37(2):409-414. PubMed ID: 34845582
[TBL] [Abstract][Full Text] [Related]
6. Determinants of COVID-19 Vaccine Hesitancy: A Cross-Sectional Study on a Mexican Population Using an Online Questionnaire (COV-AHQ).
Delgado-Gallegos JL; Padilla-Rivas GR; Zúñiga-Violante E; Avilés-Rodríguez G; Arellanos-Soto D; Gastelum-Arias LJ; Franco Villareal H; Cosío-León MLÁ; Romo-Cardenas GS; Moreno-Treviño MG; Moreno-Cuevas JE; Islas JF
Front Public Health; 2021; 9():728690. PubMed ID: 34900890
[TBL] [Abstract][Full Text] [Related]
7. Sociodemographic Factors Associated with Vaccine Hesitancy in Central Texas Immediately Prior to COVID-19 Vaccine Availability.
Litaker JR; Tamez N; Lopez Bray C; Durkalski W; Taylor R
Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010634
[TBL] [Abstract][Full Text] [Related]
8. Direct and Indirect Associations of Media Use With COVID-19 Vaccine Hesitancy in South Korea: Cross-sectional Web-Based Survey.
Lee M; You M
J Med Internet Res; 2022 Jan; 24(1):e32329. PubMed ID: 34870605
[TBL] [Abstract][Full Text] [Related]
9. Changes in COVID-19 Vaccine Hesitancy Among Black and White Individuals in the US.
Padamsee TJ; Bond RM; Dixon GN; Hovick SR; Na K; Nisbet EC; Wegener DT; Garrett RK
JAMA Netw Open; 2022 Jan; 5(1):e2144470. PubMed ID: 35061038
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 Vaccine-Related Attitudes and Beliefs in Canada: National Cross-sectional Survey and Cluster Analysis.
Benham JL; Atabati O; Oxoby RJ; Mourali M; Shaffer B; Sheikh H; Boucher JC; Constantinescu C; Parsons Leigh J; Ivers NM; Ratzan SC; Fullerton MM; Tang T; Manns BJ; Marshall DA; Hu J; Lang R
JMIR Public Health Surveill; 2021 Dec; 7(12):e30424. PubMed ID: 34779784
[TBL] [Abstract][Full Text] [Related]
11. Sociodemographic Determinants of COVID-19 Vaccine Hesitancy, Fear of Infection, and Protection Self-Efficacy.
McElfish PA; Willis DE; Shah SK; Bryant-Moore K; Rojo MO; Selig JP
J Prim Care Community Health; 2021; 12():21501327211040746. PubMed ID: 34427126
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population.
Edwards B; Biddle N; Gray M; Sollis K
PLoS One; 2021; 16(3):e0248892. PubMed ID: 33760836
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 Vaccine Hesitancy Among Chinese Population: A Large-Scale National Study.
Wu J; Li Q; Silver Tarimo C; Wang M; Gu J; Wei W; Ma M; Zhao L; Mu Z; Miao Y
Front Immunol; 2021; 12():781161. PubMed ID: 34912346
[TBL] [Abstract][Full Text] [Related]
14. Vaccine Hesitancy and Exposure to Misinformation: a Survey Analysis.
Neely SR; Eldredge C; Ersing R; Remington C
J Gen Intern Med; 2022 Jan; 37(1):179-187. PubMed ID: 34671900
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey.
Tsai R; Hervey J; Hoffman K; Wood J; Johnson J; Deighton D; Clermont D; Loew B; Goldberg SL
JMIR Public Health Surveill; 2022 Jan; 8(1):e29872. PubMed ID: 34709184
[TBL] [Abstract][Full Text] [Related]
16. Leveraging 13 million responses to the U.S. COVID-19 Trends and Impact Survey to examine vaccine hesitancy, vaccination, and mask wearing, January 2021-February 2022.
Nguyen QC; Yardi I; Gutierrez FXM; Mane H; Yue X
BMC Public Health; 2022 Oct; 22(1):1911. PubMed ID: 36229804
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics.
Schwarzinger M; Watson V; Arwidson P; Alla F; Luchini S
Lancet Public Health; 2021 Apr; 6(4):e210-e221. PubMed ID: 33556325
[TBL] [Abstract][Full Text] [Related]
18. Political Ideologies, Government Trust, and COVID-19 Vaccine Hesitancy in South Korea: A Cross-Sectional Survey.
Park HK; Ham JH; Jang DH; Lee JY; Jang WM
Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682401
[TBL] [Abstract][Full Text] [Related]
19. The prevalence and determinants of COVID-19 vaccine hesitancy in the age of infodemic.
Ouyang H; Ma X; Wu X
Hum Vaccin Immunother; 2022 Dec; 18(1):2013694. PubMed ID: 35172676
[TBL] [Abstract][Full Text] [Related]
20. Vaccine hesitancy among people with multiple sclerosis.
Yap SM; Al Hinai M; Gaughan M; Callanan I; Kearney H; Tubridy N; McGuigan C
Mult Scler Relat Disord; 2021 Nov; 56():103236. PubMed ID: 34507240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
